Mimedx (MDXG) EBT Growth (5y) (2016 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EBT Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn |
| 10 | Mimedx | 676.17 Mn | 540.33 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.38% |
| Mar 31, 2026 | -12.99% |
| Dec 31, 2025 | 26.49% |
| Sep 30, 2025 | 26.03% |
| Jun 30, 2025 | 28.78% |
| Mar 31, 2025 | 20.44% |
| Dec 31, 2024 | 28.84% |
| Sep 30, 2024 | -1.10% |
| Jun 30, 2024 | 27.37% |
| Mar 31, 2024 | 23.41% |
| Dec 31, 2023 | 29.16% |
| Sep 30, 2023 | 82.03% |
| Jun 30, 2023 | 38.65% |
| Mar 31, 2023 | -21.21% |
| Dec 31, 2022 | -12.22% |
| Sep 30, 2022 | -21.43% |
| Jun 30, 2022 | -28.69% |
| Mar 31, 2022 | -30.09% |
| Dec 31, 2021 | 14.99% |
| Sep 30, 2021 | -19.55% |